KRAS and colorectal carcinoma: Although there is some variability in studies, most large retrospective studies have demonstrated an association between KRAS G12C mutations and worse progression-free survival (PFS) and overall survival (OS) when compared with other KRAS-mutated CRC (13, 14, 19, 20).